Povidone iodine, hydrogen peroxide and chlorhexidine mouthwashes reduce SARS-CoV2 burden in whole mouth fluid and respiratory droplets
Jayaraman et al.,
Povidone iodine, hydrogen peroxide and chlorhexidine mouthwashes reduce SARS-CoV2 burden in whole mouth fluid..,
medRxiv, doi:10.1101/2021.02.25.21252488 (Preprint)
Study of SARS-CoV2 burden in whole mouth fluid and respiratory droplets with povidone iodine, hydrogen peroxide, and chlorhexidine mouthwashes in 36 hospitalized COVID-19 patients using PCR and rapid antigen testing. There were significant reductions in SARS-CoV2 burden with all treatments in both respiratory droplets and whole mouth fluid.
Jayaraman et al., 1 Mar 2021, prospective, India, preprint, 12 authors.
Abstract: medRxiv preprint doi: https://doi.org/10.1101/2021.02.25.21252488; this version posted March 1, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .
Povidone iodine, hydrogen peroxide and chlorhexidine mouthwashes reduce SARS-CoV2
burden in whole mouth fluid and respiratory droplets
Bagavad Gita Jayaraman1*, Gunaseelan Rajan1, Priya Kannian2*, Chandra Lavanya4, Krittika
Ravichandran1, Nagalingeswaran Kumarasamy3, Kannan Ranganathan4, Veeraraghavan Aswini2,
Pasuvaraj Mahanathi2, Stephen Challacombe5, Jennifer Webster-Cyriaque6, Newell W
Johnson1,3,5,7
1
2
Chennai Dental Research Foundation, Chennai, India
VHS Laboratory Services, Department of Clinical Research, VHS Hospital, Chennai, India
3
VHS-Infectious Diseases Medical Centre, VHS Hospital, Chennai, India
4
Department of Oral Pathology, Ragas Dental College and Hospital, Chennai, India
5
Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College London, UK
6
University of North Carolina, Chapel Hill, USA
7
Menzies Health Institute Queensland, Griffith University, Queensland, Australia
Address for Correspondence:
* Dr. Bagavad Gita Jayaraman
Research Scientist
Chennai Dental Research Foundation
No. 56, Dr. R. K. Salai
6th Floor, Mylapore
Chennai – 600004
Tamil Nadu, India
Ph: 91-44-42103440
Email: gita70.geetha@gmail.com
* Dr. Priya Kannian
Scientist & Head
Department of Clinical Research
VHS Hospital
Rajiv Gandhi Salai
Taramani, Chennai – 600113
Tamil Nadu, India
Ph: 91-44-22541972
Email: priyakannian@gmail.com
Word count: 599 words
1
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.
medRxiv preprint doi: https://doi.org/10.1101/2021.02.25.21252488; this version posted March 1, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit